5肖云彩 程刚 邹梅娟.Eudragit Ne 30D 为衣材制备茶碱结肠定位释药包衣片剂的研究 [J].沈阳药科大学学报,2001,18:5-7.
6.中国药典[S]2000年版：二部[M].,2000.附录XVE.
7Tozaki H, Emi Y, Horisaka E, et al. Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents:implications in peptide delivery to the colon [J ].J Pharm Pharmacol, 1997,49:164.
8Prakash A, Markham A. Oral delayed-release mesalazine: a review of its use in ulcerative colitis and Crohn' s disease [ J ]. Drugs,1999,57(3) :383.
9Tozaki H, Fujita T, Odoriba T, et al. Colon-specific delivery of R68070, a new thromboxene synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic alid-induced ulcerative colitis in rats [J]. Life Sci, 1999;64(b) : 1155.
10Bai JP,Chang LL,Guo JH.Targeting of peptide and protein drugs to specific sites in the oral route[J].Crit Rev Ther Drug Carrier Syst,1995,12(4)∶339-346.
1Spencer C M, Faulds D. Paclitaxel, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer E J. Drugs,1994,48(5) . 794847.
2Boyle D A,Goldspiel B R. A review of paclitaxel (Tax- ol) administration, stability, and compatibility issues [J. Clin J Oncol Nurs,1998,2(4) :141-145.
3Cortese B, Bertoletti A. Paclitaxel coated balloons for coronary artery interventions: A comprehensive review of preclinical and clinical data [J. Int J Cardiol, 2011, 161(1) ,4-12.
4Santos H A,Bimbo L M,Lehto V P, et al. Multifunc- tional porous silicon for therapeutic drug delivery and imaging [J- Curr Drug Discov Technol, 2011, 8(3): 228-249.
